Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Fuse Vectors has raised $5.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2025.
Fuse Vectors's investors include BioInnovation Institute, HCVC, Export and Investment Fund, BioInnovation Institute Venture Lab, BioInnovation Institute Venture House.
Fuse Vectors is headquartered in Copenhagen, Denmark.
Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Fuse Vectors is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fuse Vectors — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/fuse-vectors. Accessed August 15, 2026.
VCBacked. (2025). Fuse Vectors — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/fuse-vectors
{{cite web |title=Fuse Vectors — Funding & Investors |url=https://www.vcbacked.co/company/fuse-vectors |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated